Ureterorenoscopy with Holmium-Yttrium-Aluminum-Garnet Fragmentation Is a Safe and Efficient Technique for Stone Treatment in Patients with a Body Mass Index Superior to 30 kg/m 2

Abstract

Purpose:

The aim of the study was to analyze results and morbidity after flexible ureterorenoscopy in patients with a body mass index (BMI) >30 kg/m² and to compare with results obtained in a large cohort of nonobese patients.

Patients and Methods:

We conducted a retrospective study including all flexible ureterorenoscopy performed for stone retrieval in our institution between January 2004 and December 2008. During the study period, 224 procedures were performed, of which 18 had to be excluded because of missing BMI data. Thus, a total of 206 procedures were included in the final analysis (34 in 29 obese patients, 172 in 149 nonobese patients). Characteristics of the patients (age, BMI, previous treatment), stones (nature, location, number), and procedures (operating time, morbidity, outcome) were analyzed. Success was defined as clear imaging (completely stone free) on renal tomography and ultrasonography at 1, 3, and 6 months follow-up.

Results:

Mean BMI was 34±0.6 kg/m² in obese patients (OP) and 24±0.2 kg/m² in nonobese patients (NOP). Mean stone size, location, and composition were not significantly different between groups. Operative time was also similar in OP and NOP (102.5±6.1 min vs 103±3.4 min, P=NS). The rate of minor complications (fever, hematuria, flank pain) was similar in OP (11.8%) and NOP (11.4%). No major complication necessitating prolonged hospital stay or new surgical procedure was observed. The overall stone-free rate was not significantly different between OP (79.4%) and NOP (70%).

Conclusion:

Flexible ureterorenoscopy is an appropriate treatment for use in obese patients and achieves excellent stone-free rates with low morbidity.

Get full access to this article

View all access options for this article.

References

de Saint Pol

. Evolution of obesity by social status in France, 1981-2003. Econ Hum Biol, 2009; 7:398–404.

Pasulka

, Bistrian

, Benotti

, Blackburn

. The risks of surgery in obese patients. Ann Intern Med, 1986; 104:540–546.

Traxer

, Lechevallier

, Saussine

et al.

[Metabolic syndrome and urolithiasis. A new concept for the urologist]

(Fre) Prog Urol, 2008; 18:828–831.

Duffey

, Pedro

, Kriedberg

et al. Lithogenic risk factors in the morbidly obese population. J Urol, 2008; 179:1401–1406.

Preminger

, Tiselius

, Assimos

et al. 2007 Guideline for the management of ureteral calculi. Eur Urol, 2007; 52:1610–1631.

Conort

, Doré

, Saussine

. [Guidelines for the urological management of renal and ureteric stones in adults] (Fre) Prog Urol, 2004; 14:1095–1102.

Türk

, TK , Knoll

, Petrik

et al. Guidelines on Urolithiasis. 2011. http://www.uroweb.org/gls/pdf/18_Urolithiasis.pdf. 2011 December 9,

Dash

, Schuster

, Hollenbeck

et al. Ureteroscopic treatment of renal calculi in morbidly obese patients: A stone-matched comparison. Urology, 2002; 60:393–397.

Andreoni

, Afane

, Olweny

, Clayman

. Flexible ureteroscopic lithotripsy: First-line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol, 2001; 15:493–498.

10.

Bultitude

, Tiptaft

, Dasgupta

, Glass

. Treatment of urolithiasis in the morbidly obese. Obes Surg, 2004; 14:300–304.

11.

Clavien

, Barkun

, de Oliveira

et al. The Clavien-Dindo classification of surgical complications: Five-year experience. Ann Surg, 2009; 250:187–196.

12.

Stevens

, Cai

, Pamuk

et al. The effect of age on the association between body-mass index and mortality. N Engl J Med, 1998; 338:1–7.

13.

Asplin

. Obesity and urolithiasis. Adv Chronic Kidney Dis, 2009; 16:11–20.

14.

Grasso

. Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am, 2000; 27:623–631.

15.

Robert

, A'Ch

, Lanfrey

et al. Piezoelectric shockwave lithotripsy of urinary calculi: Comparative study of stone depth in kidney and ureter treatments. J Endourol, 1999; 13:699–703.

16.

Tomaszewski

, Smaldone

, Schuster

et al. Outcomes of percutaneous nephrolithotomy stratified by body mass index. J Endourol, 2010; 24:547–550.

17.

Hammad

, Balakrishnan

. The effect of fat and nonfat components of the skin-to-stone distance on shockwave lithotripsy outcome. J Endourol, 2010; 24:1825–1829.

18.

Olivi

, Vedrine

, Costilles

et al.

[Extra corporeal shock wave lithotripsy in patients with body mass index over 35 Kg/m2]

(Fre) Prog Urol, 2011; 21:254–259.

19.

Thomas

, Cass

. Extracorporeal shock wave lithotripsy in morbidly obese patients. J Urol, 1993; 150:30–32.

20.

Pearle

, Nakada

, Womack

, Kryger

. Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol, 1998; 160:669–673.

21.

Farina Pérez

, Zungri Telo

. [Valdivia supine position as the best option for percutaneous surgery of renal calculi in morbidly obese patients] (Spa) Actas Urol Esp, 2005; 29:997–1000.

22.

Faerber

, Goh

. Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol, 1997; 3:89–95.

23.

Karlsen

, Renkel

, Tahir

et al. Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: Prospective effectiveness patient-preference trial. J Endourol, 2007; 21:28–33.

24.

Grasso

, Ficazzola

. Retrograde ureteropyeloscopy for lower pole caliceal calculi. J Urol, 1999; 162:1904–1908.

25.

Wheat

, Roberts

, Wolf

Jr.

Multi-session retrograde endoscopic lithotripsy of large renal calculi in obese patients. Can J Urol, 2009; 16:4915–4920.

26.

Lechevallier

, Traxer

, Saussine

. [Management of renal stones] (Fre) Prog Urol, 2008; 18:959–962.